Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
肾移植受者从钙调神经磷酸酶抑制剂转换为贝拉西普治疗后的心血管风险:一项随机临床试验
期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2022.100574
Bredewold, Obbo W; Chan, Joe; Svensson, My; Bruchfeld, Annette; de Fijter, Johan W; Furuland, Hans; Grinyo, Josep M; Hartmann, Anders; Holdaas, Hallvard; Hellberg, Olof; Jardine, Alan; Mjörnstedt, Lars; Skov, Karin; Smerud, Knut T; Soveri, Inga; Sørensen, Søren S; Zonneveld, Anton-Jan van; Fellström, Bengt